Tocqueville Asset Management L.P. Global Blood Therapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $332,100 - $698,845	-10,250 Reduced 74.55%	3,500 $238,000
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $77,040 - $106,770	3,000 Added 27.91%	13,750 $476,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $267,675 - $432,795	10,750 New	10,750 $315,000
Q1 2019 Apr 30, 2019	SELL	$39.99 - $53.48 $353,911 - $473,298	-8,850 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$31.54 - $46.67 $48,887 - $72,338	-1,550 Reduced 14.9%	8,850 $363,000
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $55,100 - $74,095	1,450 Added 16.2%	10,400 $395,000
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $23,220 - $30,090	600 Added 7.19%	8,950 $405,000
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $330,660 - $550,265	8,350 New	8,350 $403,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.